Results from the first completed clinical trial facilitated and organized by DKMS, the world’s largest stem cell donor center, suggest that adult patients who have relapsed or refractory acute myeloid leukemia should receive stem cell transplantation as soon as possible.
The world of cancer treatments continues to evolve, and for those diagnosed with blood cancers, a new option can be found in menin inhibitors—the latest form of targeted therapy in advanced acute leukemia.
